Skip to main content
The Journal of Clinical Endocrinology and Metabolism logoLink to The Journal of Clinical Endocrinology and Metabolism
. 2011 Aug 11;96(10):E1630–E1633. doi: 10.1210/jc.2011-1130

Heritability of the Weight Loss Response to Gastric Bypass Surgery

Ida J Hatoum 1, Danielle M Greenawalt 1, Chris Cotsapas 1, Marc L Reitman 1, Mark J Daly 1, Lee M Kaplan 1,
PMCID: PMC3200251  PMID: 21832118

Abstract

Context:

The use of Roux-en-Y gastric bypass (RYGB) surgery to treat severe obesity has grown dramatically. RYGB is highly effective, but the response in individual patients varies widely, and clinical predictors have been able to explain only a fraction of this variation.

Objective:

Our objective was to determine whether there is a significant genetic contribution to weight loss after RYGB.

Methods:

We genotyped 848 patients undergoing RYGB. Using identity-by-descent methods, we identified 13 pairs of first-degree relatives. We identified an additional 10 pairs of individuals who were living together but are not genetically related and randomly paired the remaining 794 individuals. We then compared weight loss within and across pairs.

Results:

First-degree relative pairs had a similar response to surgery, with a 9% mean difference in excess weight loss between members of each pair. This similarity was not seen with cohabitating individuals (26% mean difference; P = 0.005 vs. first-degree pairs) or unrelated individuals (25% mean difference; P = 0.001). Cohabitating individuals had within-pair differences in weight loss no more similar than randomly paired individuals (P = 0.60). The pair relationship explained a significant portion of the variation in weight loss in first-degree relatives [intraclass correlation coefficient (ICC) = 70.4%; P = 0.02] but not in random subjects (ICC = 0.9%; P = 0.48) or genetically unrelated cohabitating individuals (ICC = 14.3%; P = 0.67).

Conclusions:

Genetic factors strongly influence the effect of RYGB on body weight. Identification of the specific genes that mediate this effect will advance our understanding of the biological mechanisms of weight loss after RYGB and should help identify patients who will benefit the most from this intervention.


Obesity is a disorder characterized by dysregulation of complex systems affecting energy intake, energy expenditure, metabolic efficiency, and reward pathways (1). Behavioral interventions and pharmacotherapies targeting these mechanisms have had limited long-term success (25). In contrast, Roux-en-Y gastric bypass (RYGB) affects multiple physiological pathways (6), leading to substantial and sustained weight loss. Although the mechanisms underlying the clinical response to this procedure are not well understood, emerging evidence indicates that the observed effects result from surgery-induced changes in neuronal and hormonal regulation of energy balance rather than from physical restriction of food intake or malabsorption of ingested macronutrients (68).

After RYGB, patients lose an average of 70% of their excess body weight, maintaining approximately 80% of this weight loss over decades (9). Despite its excellent effects overall, however, there is wide variability in weight loss among individual patients (10). Although several clinical, demographic, psychological, and surgical predictors have been reported, these factors explain only a small fraction of the variation in weight loss after surgery (10). This observation, coupled with the observed physiological alteration in energy balance after RYGB, implies strong biological, and possibly genetic, determinants of response to surgery.

We sought to determine the contribution of genetic factors to weight loss after RYGB in a cohort of 848 patients by comparing weight loss after RYGB within pairs of genetically related and genetically unrelated individuals. We found similar weight loss after RYGB within pairs of related individuals, whereas unrelated individuals exhibited far less similarity in weight loss outcomes. Because part of this effect could be mediated through shared environmental influences, we also identified pairs of genetically unrelated individuals who were living together. Weight loss after RYGB within these environmentally related pairs was no more similar than completely unrelated pairs of individuals and much greater than between first-degree relatives. These results suggest that there are strong genetic determinants of weight loss after RYGB.

Patients and Methods

Study population

This study was approved by and performed in accordance with the guidelines of the Human Studies Committee at the Massachusetts General Hospital. We obtained consent from 1018 of 1049 (97%) consecutive patients undergoing RYGB at this institution to collect and study DNA from liver tissue samples removed at the time of surgery. The surgical method has been described previously (10). Genomic DNA was extracted from collected liver samples, and genotyping was performed using the Illumina HumanHap 650Y BeadChip array (Illumina Inc., San Diego, CA). Race was genetically determined by principal component analysis using EIGENSTRAT (11); there was 97% concordance with self-reported race. Patients were excluded if they were on weight-lowering medications after surgery (1.7%), had cancer or other severe illness (including severe postoperative complications or reoperations; 2.4%), their DNA was not available (4.7%), or their postoperative body mass index (BMI) at least 10 months after RYGB could not be determined (7.9%).

Using identity-by-descent methods (PLINK software) (12), we identified 13 first-degree relative pairs, defined as pairs of individuals who share approximately 50% of their genetic variation, six second-degree relative pairs (∼25% of genetic variation shared) and four third-degree relative pairs (∼12.5% of genetic variation shared). We excluded an additional eight patients who were genetically related to established first-degree pairs, leading to a final sample of 848 (83.3%). We then matched on genetically identified race, randomly paired 794 unrelated individuals from the cohort, and compared the similarity in their weight loss outcomes after surgery. We also identified 20 cohabitating individuals by review of the medical records of all patients who had undergone RYGB at this center. No cohabitating individuals were genetically related.

Endpoint and covariate assessment

Demographic and clinical information was extracted from the medical record. We indentified a patient's weight nadir, defined as the lowest weight achieved after at least 10 months of surgery without coexisting debilitating illness or use of weight-lowering medications. We calculated percent excess body weight lost (EBWL) at weight nadir by subtracting the patient's nadir BMI from his or her presurgical BMI and dividing this difference by the difference between the patient's initial BMI and the upper normal BMI of 25 kg/m2. Chart-derived weights were validated via telephone interviews in a subset of patients (n = 306); there was a 94% concordance between these two sources.

Statistical analyses

Average difference in outcome was calculated by pair, and analyses based on these mean differences were based on one entry per pair. Wilcoxon rank sum tests were used to test differences in mean response between groups. Linear mixed-effects models were constructed to determine the intraclass correlation coefficients (ICC) by type of relationship. All nongenetic analyses were performed using SAS statistical software (SAS Institute, Cary, NC).

Results

Preoperatively, patients in this cohort had an average BMI of 50.2 ± 8.6 kg/m2, an average age of 44.7 ± 11.3 yr, and were 74.8% female and 86% Caucasian. These characteristics were similar among the different groups studied (Supplemental Table 1, published on The Endocrine Society's Journals Online web site at http://jcem.endojournals.org). After RYGB, patients lost an average of 119.2 ± 41.7 pounds at weight nadir, corresponding to an EBWL of 79.7 ± 21.8%; the population pattern of percent excess weight loss follows the wide and normal distribution observed previously (Fig. 1) (10). To determine whether there is a genetic component to the variation in weight loss after surgery, we compared weight loss after RYGB within pairs of genetically related and genetically unrelated individuals. Unrelated individuals demonstrated far less similar weight loss after surgery than first-degree relatives (Fig. 2), with an average difference in EBWL of 25.4% in unrelated individuals and 9.9% in first-degree relatives (P = 0.001). Because the observed similarity in weight loss could result primarily from shared environmental influences, we compared weight loss within pairs of individuals who were living together but who are genetically unrelated. Pairs of these environmentally related controls had a shared response similar to completely unrelated individuals (mean 26.1% difference in EBWL; P = 0.60), a response that was substantially different from that of first-degree relatives (P = 0.005). The small number of second- and third-degree relative pairs in this cohort precludes statistical analysis of these groups.

Fig. 1.

Fig. 1.

Percent EBWL at postoperative weight nadir after RYGB in 848 patients with severe obesity.

Fig. 2.

Fig. 2.

Mean difference in percent EBWL within patient pairs, according to type of relationship. Error bars depict sem.

The ICC represents the portion of total variation in outcome explained by the pair relationship. Using mixed-effects models adjusted for age, sex, year of surgery, and preoperative BMI, the ICC were 70.4% for first-degree relatives (P = 0.02), 14.3% for environmentally related controls (P = 0.67), and 0.9% for randomly paired individuals (P = 0.48). Because preoperative BMI is strongly associated with postoperative percent EBWL (10), we additionally matched the unrelated controls based on 5-kg/m2-wide BMI groups to mimic the distribution of differences in preoperative BMI between first-degree relatives. After this adjustment, first-degree relative pairs still demonstrated significantly less difference in weight loss compared with the unrelated controls (difference in EBWL for unrelated pairs 22.3 ± 17.9%; P = 0.01 vs. first-degree relatives). Thus, first-degree relatives have weight loss outcomes after surgery that closely and significantly resemble each other, a characteristic not shared by environmentally related controls or randomly paired individuals. Similar results were seen when men and women were examined separately (data not shown).

Discussion

These results suggest that there are strong genetic determinants of weight loss after RYGB. Despite the small number of genetically related individuals in this cohort, there is demonstrably tight clustering of weight loss outcomes within pairs of first-degree relatives. Although some contribution of environmental effects cannot be excluded, this tight clustering is not seen with cohabitating individuals, indicating that there is a substantial genetic impact beyond any potential shared environmental influences. These observations underscore the biological nature of the response to RYGB and suggest that variation in the genetic background of individuals strongly influences weight loss after this operation.

The observed genetic contribution to weight loss after RYGB is consistent with a recent small case study of weight loss after bariatric surgery in four pairs of monozygotic twins. The three twin pairs who underwent RYGB exhibited nearly identical within-pair weight loss outcomes after surgery. Interestingly, the twins who underwent adjustable gastric banding had widely dissimilar weight loss outcomes (13). Although the size of our cohort limits the power to identify the specific genetic signals associated with weight loss by genome-wide association study, we tested the limited number of single-nucleotide polymorphisms known to be associated with the development of obesity. There was no association between any of these 32 genetic loci and weight loss after this procedure (data not shown), a finding that has also been observed in other cohorts (14, 15). A recent report by Gerhard and colleagues (16) suggests that high allelic burden from multiple obesity-associated polymorphisms may be associated with less weight loss after RYGB in surgical patients with relatively low preoperative BMI (<50 kg/m2). It is therefore likely that large-scale genome-wide association studies using one or more large cohorts followed by extensive replication will be required to identify the relevant genetic contributors. This unsupervised approach can yield insight into previously unidentified or unanticipated physiological mechanisms of weight loss after surgery, which appear to be different from the mechanisms that lead to severe obesity in the first place.

The specific biological mechanisms of weight loss after bariatric surgery are poorly understood. Traditional thinking was that weight loss after RYGB resulted from mechanical restriction of food intake and/or calorie malabsorption. However, studies in both rodents and humans demonstrate that macronutrients are not malabsorbed after this operation (17). Moreover, under conditions of caloric restriction, the body responds by decreasing energy expenditure (18), but recent animal and human evidence indicates that this metabolic adaptation is blunted or blocked after RYGB despite a dramatic decrease in food consumption; indeed, both rats and mice exhibit increased energy expenditure after RYGB (6). Studies comparing RYGB to other gastrointestinal weight loss procedures that only decrease the size of the stomach to one comparable to RYGB (e.g. adjustable gastric banding) show that RYGB confers much greater weight loss (7). Thus, the mechanisms of weight loss after RYGB appear far more complex than mere restriction or malabsorption alone. The findings in this study support a physiological mechanism of response to this operation and suggest that biological determinants account for the wide variation in weight loss outcomes among patients.

In conclusion, these data demonstrate that genetic factors explain a significant portion of the variation in weight loss after RYGB. This observation provides additional support for a physiological mechanism of response to surgery. Discovery of the specific genes that predict this response will provide important clues to the molecular mechanisms that account for the high efficacy and long durability of response to RYGB and will advance our understanding of the biological mechanisms of weight loss after this procedure. Moreover, understanding of the profound response to RYGB should illuminate key features of the normal regulation of energy balance and body weight independent of surgery. Identifying these mechanisms will facilitate the development of more effective nonsurgical therapies for obesity that exploit these surgical mechanisms. Determination of the predictive polymorphisms could also lead to the development of tools to distinguish those patients who are likely to benefit most from RYGB. Use of such predictive tools could aid in the optimal selection of patients for RYGB and further improve the risk-to-benefit profile for this highly effective yet invasive treatment.

Supplementary Material

Supplemental Data

Acknowledgments

This work was supported by National Institutes of Health Grants DK088661 (to L.M.K.) and DK090956 (to L.M.K.), a research grant from Merck Research Laboratories (to L.M.K.), and a research grant from Ethicon Endosurgery (L.M.K.).

Disclosure Summary: I.J.H., C.C., and M.J.D. have nothing to declare. L.M.K. reports a research grant from Merck Research Laboratories. D.M.G. and M.L.R. report employment by Merck Research Laboratories.

Footnotes

Abbreviations:
BMI
Body mass index
EBWL
excess body weight loss
ICC
intraclass correlation coefficient
RYGB
Roux-en-Y gastric bypass.

References

  • 1. O'Rahilly S, Farooqi IS. 2008. Human obesity: a heritable neurobehavioral disorder that is highly sensitive to environmental conditions. Diabetes 57:2905–2910 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Wing RR. 2010. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 170:1566–1575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, Kraemer HC, King AC. 2007. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA 297:969–977 [DOI] [PubMed] [Google Scholar]
  • 4. Bray GA. 2008. Medications for weight reduction. Endocrinol Metab Clin North Am 37:923–942 [DOI] [PubMed] [Google Scholar]
  • 5. Kaplan LM. 2010. Pharmacologic therapies for obesity. Gastroenterol Clin North Am 39:69–79 [DOI] [PubMed] [Google Scholar]
  • 6. Stylopoulos N, Hoppin AG, Kaplan LM. 2009. Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity 17:1839–1847 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. 2004. Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737 [DOI] [PubMed] [Google Scholar]
  • 8. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E. 2004. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240:236–242 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM. 2007. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752 [DOI] [PubMed] [Google Scholar]
  • 10. Hatoum IJ, Stein HK, Merrifield BF, Kaplan LM. 2009. Capacity for physical activity predicts weight loss after Roux-en-Y gastric bypass. Obesity 17:92–99 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904–909 [DOI] [PubMed] [Google Scholar]
  • 12. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Hagedorn JC, Morton JM. 2007. Nature versus nurture: identical twins and bariatric surgery. Obes Surg 17:728–731 [DOI] [PubMed] [Google Scholar]
  • 14. Sarzynski MA, Jacobson P, Rankinen T, Carlsson B, Sjöström L, Bouchard C, Carlsson LM. 2011. Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes (Lond) 35:676–683 [DOI] [PubMed] [Google Scholar]
  • 15. Aslan IR, Campos GM, Calton MA, Evans DS, Merriman RB, Vaisse C. 2011. Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes Surg 21:930–934 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Still CD, Wood GC, Chu X, Erdman R, Manney CH, Benotti PN, Petrick AT, Strodel WE, Mirshahi UL, Mirshahi T, Carey DJ, Gerhard GS. 10 February 2011. High allelic burden of four obesity SNPs is associated with poorer weight loss outcomes following gastric bypass surgery. Obesity 19:1676–1683 [DOI] [PubMed] [Google Scholar]
  • 17. Kaplan LM. 2003. Body weight regulation and obesity. J Gastrointest Surg 7:443–451 [DOI] [PubMed] [Google Scholar]
  • 18. MacLean PS, Higgins JA, Johnson GC, Fleming-Elder BK, Donahoo WT, Melanson EL, Hill JO. 2004. Enhanced metabolic efficiency contributes to weight regain after weight loss in obesity-prone rats. Am J Physiol Regul Integr Comp Physiol 287:R1306–R1315 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data

Articles from The Journal of Clinical Endocrinology and Metabolism are provided here courtesy of The Endocrine Society

RESOURCES

OSZAR »